Regarding CKD-associated anemia, murine in vivo studies suggest that FGF23 may have inhibitory effects on erythropoiesis [34, 35] and, in the CRIC study, higher FGF23 levels were independently associated with prevalent and incident anemia [36]. Here, FGF23 is linked to chronic kidney disease.